Payer & Market Access Expert - Gross-to-Net & Formulary Strategy

United StatesRemotePart-timemid

OtherStrategy

1 views0 saves0 applied

Apply Now

Quick Summary

Technical Tools

OtherStrategy

What We Offer

~1 min read

A leading biotech and pharmaceutical research organization is conducting a paid expert-evaluation initiative focused on improving how AI systems analyze commercial drugs and drug-development programs.

We are seeking an experienced Payer & Market Access Expert with strong knowledge of pricing, reimbursement, gross-to-net dynamics, rebates, and formulary strategy. You will help create and evaluate structured rubrics designed to assess whether AI-generated analyses accurately reflect real-world payer and market access practices.

This is a paid pilot engagement with the potential for continued work as the program expands.

Requirements

~1 min read

5+ years of professional experience in market access, pricing and reimbursement, managed markets, payer strategy, or a closely related field.
Currently based in the United States.
Hands-on understanding of gross-to-net modeling, rebates, discounts, formulary tiering, and payer coverage dynamics.
Familiarity with biotech and pharmaceutical drug-development programs and commercialization processes.
Strong understanding of how payer behavior varies across drug classes, therapeutic categories, and commercial situations.
Ability to critically evaluate assumptions and determine whether they are commercially realistic and supported by industry practice.
Strong analytical reasoning and attention to detail.
Excellent written communication skills, with the ability to clearly explain the rationale behind professional judgments.
Comfortable working independently and providing structured feedback within defined evaluation frameworks.

Responsibilities

~1 min read

→ Create, review, and critique evaluation rubrics for analyzing commercial drugs and pharmaceutical development programs.
→ Establish and pressure-test gross-to-net assumptions, including rebates, discounts, and other pricing considerations across relevant drug classes.
→ Evaluate whether assumptions regarding formulary placement, coverage, utilization management, and payer behavior accurately reflect real-world market access practices.
→ Assess payer and reimbursement considerations across different therapeutic areas and drug classes.
→ Apply market access expertise consistently across the pilot's assigned portfolio of drugs and development programs.
→ Identify unrealistic, incomplete, or unsupported assumptions and provide clear recommendations for improving evaluation criteria.
→ Help ensure rubrics are practical, rigorous, and aligned with how experienced payer and market access professionals evaluate commercial opportunities.

Duration: Approximately 10–20 hours over a 1–2 week pilot.
Location: Fully remote, United States.
Engagement Type: Paid expert evaluation pilot.
Potential Extension: Strong contributors may have opportunities for recurring engagements as the program expands.